Lupin Ltd has acquired the anti-diabetic medicine Huminsulin in India from Eli Lilly to expand its diabetes portfolio. This move aims to provide high-quality, affordable healthcare for diabetes patients. Huminsulin is used for treating Type 1 and Type 2 diabetes to improve blood sugar control.
